English | 简体中文 | 繁體中文 | 한국어
 All Press Releases

UK advertising reports GBP36.6bn spend in 2023
Apr 26, 2024 17:30 HKT
CanSinoBIO CSO Shares the Latest Results of the Company's Globally Innovative Pneumococcal Vaccine
Apr 26, 2024 15:36 HKT
可持续发展三大支柱引领 海通恒信ESG必答卷高分亮相
Apr 26, 2024 15:28 HKT
可持續發展三大支柱引領 海通恆信ESG必答卷高分亮相
Apr 26, 2024 15:25 HKT
Internationally Renowned Botulinum Toxin Experts Join WizMedi Bio's New Botulinum Toxin Development Project
Apr 26, 2024 14:34 HKT
スパークス・グループによる「宇宙フロンティア2号ファンド」の設立について
Apr 26, 2024 14:00 HKT
中滙集團公佈2024財年中期業績
Apr 26, 2024 13:51 HKT
Edvantage Group Announces FY2024 Interim Results
Apr 26, 2024 13:43 HKT
Internationally Renowned Botulinum Toxin Experts Join WizMedi Bio's New Botulinum Toxin Development Project
Apr 26, 2024 13:27 HKT
Imexpharm Corporation Hosts Shareholders, Analysts and Potential Investors at its 2024 Annual General Meeting
Apr 26, 2024 13:16 HKT
JCB enables JCB Contactless acceptance at Taichung MRT in Taiwan
Apr 26, 2024 09:00 HKT
Jeff Martin Auctioneers to Manage Sale of Sabine Mining Company Assets for North American Coal
Apr 26, 2024 08:00 HKT
Cambridge Isotope Laboratories (CIL) Shows Long-Term Commitment to Xenia, Ohio, Facility With New Land Purchase
Apr 25, 2024 21:00 HKT
黑桃资本向香港红十字会捐赠艺术珠宝收藏品
Apr 25, 2024 20:53 HKT
黑桃資本向香港紅十字會捐贈藝術珠寶收藏品
Apr 25, 2024 20:48 HKT
Black Spade Donates Art and Jewellery Collection To Hong Kong Red Cross
Apr 25, 2024 20:40 HKT
Q2 Metals Announces Assay Results from Its 2023 Inaugural Drill Program at the Mia Lithium Property, James Bay Territory, Quebec, Canada
Apr 25, 2024 19:09 HKT
【最新弹床好去处推介】将军澳中心x Kiztopia星际弹游太空站
Apr 25, 2024 18:05 HKT
【最新彈床好去處推介】將軍澳中心x Kiztopia星際彈遊太空站
Apr 25, 2024 18:00 HKT
Mazda Production and Sales Results for March 2024 and for April 2023 through March 2024
Apr 25, 2024 17:21 HKT
Next >>
 Releases By Language
All
English
Indonesian
Japanese
Korean
Thai
Trad. Chinese
Simp. Chinese
Vietnamese
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: